Zeria Pharmaceutical Co Ltd (4559) – Financial and Strategic SWOT Analysis Review

Zeria Pharmaceutical Co Ltd (4559) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $300

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
25
Pharmaceuticals and Healthcare
Japan

Summary

Zeria Pharmaceutical Co Ltd (Zeria) is a pharmaceutical company. The company manufactures, imports and exports pharmaceuticals, veterinary pharmaceuticals, non-pharmaceutical products, agricultural chemicals, and industrial chemicals and reagents. It also manufactures and sells cosmetics, alcoholic beverages, food additives, health foods, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, carbonated beverages, beauty appliances, measuring equipment, and analytical equipments. Zeria offers ethical products such as acinon tablets, a histamine h2 receptor antagonist, promac granules and d tablets, new lecicarbon suppositories, visiclear combination tablets, peon tablets, landel tablets, avitene and syringe avitene, among others. Zeria is headquartered in Chuo-ku, Tokyo, Japan.

This comprehensive SWOT profile of Zeria Pharmaceutical Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Zeria Pharmaceutical Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including

*,

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include

,

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



Table of Contents

Section 1 – About the Company

Zeria Pharmaceutical Co Ltd – Key Information
Zeria Pharmaceutical Co Ltd – Overview
Zeria Pharmaceutical Co Ltd – Key Employees
Zeria Pharmaceutical Co Ltd – Key Employee Biographies
Zeria Pharmaceutical Co Ltd – Key Operational Heads
Zeria Pharmaceutical Co Ltd – Major Products and Services
Zeria Pharmaceutical Co Ltd – History
Zeria Pharmaceutical Co Ltd – Company Statement
Zeria Pharmaceutical Co Ltd – Locations And Subsidiaries
Zeria Pharmaceutical Co Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Zeria Pharmaceutical Co Ltd – Business Description
Zeria Pharmaceutical Co Ltd – Corporate Strategy
Zeria Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Zeria Pharmaceutical Co Ltd – Strengths
Zeria Pharmaceutical Co Ltd – Weaknesses
Zeria Pharmaceutical Co Ltd – Opportunities
Zeria Pharmaceutical Co Ltd – Threats
Zeria Pharmaceutical Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Zeria Pharmaceutical Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company



List of Tables

Zeria Pharmaceutical Co Ltd, Key Information
Zeria Pharmaceutical Co Ltd, Key Ratios
Zeria Pharmaceutical Co Ltd, Share Data
Zeria Pharmaceutical Co Ltd, Major Products and Services
Zeria Pharmaceutical Co Ltd, History
Zeria Pharmaceutical Co Ltd, Key Employees
Zeria Pharmaceutical Co Ltd, Key Employee Biographies
Zeria Pharmaceutical Co Ltd, Key Operational Heads
Zeria Pharmaceutical Co Ltd, Other Locations
Zeria Pharmaceutical Co Ltd, Subsidiaries
Zeria Pharmaceutical Co Ltd, Key Manufacturing facilities
Zeria Pharmaceutical Co Ltd, Key Competitors
Zeria Pharmaceutical Co Ltd, SWOT Analysis
Zeria Pharmaceutical Co Ltd, Ratios based on current share price
Zeria Pharmaceutical Co Ltd, Annual Ratios
Zeria Pharmaceutical Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios



List of Figures

Zeria Pharmaceutical Co Ltd, Performance Chart
Zeria Pharmaceutical Co Ltd, Ratio Charts

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $300

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.